Thus, their corresponding ligands such as CCL5, CXCL9, CXCL10, and CX3CL1 effectively guide CD8+ CTL mobilization from regional lymph nodes to tumor tissues [18]. This evidence concerns the gene CX3CL1 and neoplasm.